154 related articles for article (PubMed ID: 32108548)
1. Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.
Hobbs M; Patel R; Morrison PD; Kalk N; Stone JM
J Psychopharmacol; 2020 Jun; 34(6):648-653. PubMed ID: 32108548
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.
Shalit N; Barzilay R; Shoval G; Shlosberg D; Mor N; Zweigenhaft N; Weizman A; Krivoy A
J Clin Psychiatry; 2016 Aug; 77(8):e989-95. PubMed ID: 27379411
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
[TBL] [Abstract][Full Text] [Related]
4. The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
Bassir Nia A; Mann CL; Spriggs S; DeFrancisco DR; Carbonaro S; Parvez L; Galynker II; Perkel CA; Hurd YL
J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31265768
[TBL] [Abstract][Full Text] [Related]
5. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency Setting.
Manseau MW; Rajparia A; Joseph A; Azarchi S; Goff D; Satodiya R; Lewis CF
Subst Use Misuse; 2017 May; 52(6):822-825. PubMed ID: 28156305
[TBL] [Abstract][Full Text] [Related]
7. A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes.
Blevins CE; Banes KE; Stephens RS; Walker DD; Roffman RA
Addict Behav; 2016 Dec; 63():114-9. PubMed ID: 27454353
[TBL] [Abstract][Full Text] [Related]
8. A Polydrug and Psychosocial Profile of Synthetic Cannabinoid Use in a New York City Community Sample, 2016-2017.
Joseph A; Lekas HM; Manseau M; Lewis C
Subst Use Misuse; 2019; 54(2):282-287. PubMed ID: 30526203
[TBL] [Abstract][Full Text] [Related]
9. An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland.
Wilkins C; Prasad J; Wong KC; Rychert M; Graydon-Guy T
N Z Med J; 2016 Mar; 129(1431):51-8. PubMed ID: 27005874
[TBL] [Abstract][Full Text] [Related]
10. Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users.
Deng H; Desai PV; Mohite S; Okusaga OO; Zhang XY; Nielsen DA; Kosten TR
J Stud Alcohol Drugs; 2019 Mar; 80(2):230-235. PubMed ID: 31014468
[TBL] [Abstract][Full Text] [Related]
11. Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users.
Cohen K; Rosenzweig S; Rosca P; Pinhasov A; Weizman A; Weinstein A
Front Psychiatry; 2020; 11():355. PubMed ID: 32477173
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
[TBL] [Abstract][Full Text] [Related]
13. Housing outcomes and predictors of success: the role of hospitalization in street outreach.
Lettner BH; Doan RJ; Miettinen AW
J Psychiatr Ment Health Nurs; 2016 Mar; 23(2):98-107. PubMed ID: 26914865
[TBL] [Abstract][Full Text] [Related]
14. Synthetic cannabinoid use among college students.
Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and synthetic cannabinoids as a cause of death: Trends and their healthcare implications.
Suriaga A; Tappen RM; Aston ER; Chiang-Hanisko L; Newman D
J Nurs Scholarsh; 2023 May; 55(3):623-636. PubMed ID: 36250599
[TBL] [Abstract][Full Text] [Related]
16. Substance Use, Homelessness, Mental Illness and Medicaid Coverage: A Set-up for High Emergency Department Utilization.
Moulin A; Evans EJ; Xing G; Melnikow J
West J Emerg Med; 2018 Nov; 19(6):902-906. PubMed ID: 30429919
[TBL] [Abstract][Full Text] [Related]
17. Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility.
Cohen K; Mama Y; Rosca P; Pinhasov A; Weinstein A
Front Psychiatry; 2020; 11():602. PubMed ID: 32695029
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Cannabinoid Use Among High School Seniors.
Palamar JJ; Barratt MJ; Coney L; Martins SS
Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28893851
[TBL] [Abstract][Full Text] [Related]
19. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
20. New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
Alhassan A; Prahad SR; Burk BG; Fargason RE; Birur B
Psychopharmacol Bull; 2024 Mar; 54(1):33-39. PubMed ID: 38449474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
